help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isola, J. J.
Right arrow Articles by Waldman, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isola, J. J.
Right arrow Articles by Waldman, F. M.

American Journal of Pathology, Vol 147, 905-911, Copyright © 1995 by American Society for Investigative Pathology


REGULAR ARTICLES

Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer

JJ Isola, OP Kallioniemi, LW Chu, SA Fuqua, SG Hilsenbeck, CK Osborne and FM Waldman
Department of Laboratory Medicine, University of California, San Francisco, USA.

Breast cancer progression is determined by a complex pattern of multiple genetic aberrations the association of which with patient prognosis is unknown. In this study, we have undertaken a genome-wide screening to detect genetic changes associated with clinical outcome in node-negative breast cancer. Comparative genomic hybridization was used to screen for DNA sequence gains and losses across all human chromosomes in 23 tumors from node-negative breast cancer patients with no disease recurrence after at least 5 years of follow-up and in 25 node-negative patients with recurrence during the first 5 years of follow-up. The total number of genetic aberrations (copy number gains and losses) per tumor was significantly greater in the recurrence group (P = 0.019) and in the subgroup of these patients who died as a result of breast cancer (P = 0.0022). When copy number losses and gains were analyzed separately, only losses were significant (P = 0.013 for recurrence and P = 0.002 for overall survival). Of the individual loci involved, a high level gain of the long arm of chromosome 8 was significantly associated with recurrence (P = 0.01, Fisher's exact test). Furthermore, amplification of DNA sequences at chromosome 20q12- 13 was found in 7 cases (15%), 6 of which had early recurrence within 32 months of diagnosis. This genome-wide overview by comparative genomic hybridization suggests that genetically advanced node-negative breast cancers having a high overall number of genetic aberrations may have a poor prognosis and that increased copy number of two specific regions, 8q and 20q13, may confer a more aggressive phenotype. Results of this pilot study suggest that determination of the total number of DNA sequence copy number aberrations may help therapeutic decision making. Specific probes should be developed to test the prognostic value of 8q and 20q12-13 amplifications in large numbers of patients.


This article has been cited by other articles:


Home page
Mol Cancer ResHome page
J.-P. Kilday, R. Rahman, S. Dyer, L. Ridley, J. Lowe, B. Coyle, and R. Grundy
Pediatric Ependymoma: Biological Perspectives
Mol. Cancer Res., June 1, 2009; 7(6): 765 - 786.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhang, J. W.M. Martens, J. X. Yu, J. Jiang, A. M. Sieuwerts, M. Smid, J. G.M. Klijn, Y. Wang, and J. A. Foekens
Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer
Cancer Res., May 1, 2009; 69(9): 3795 - 3801.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. V. Iakovlev, N. C.R. Arneson, V. Wong, C. Wang, S. Leung, G. Iakovleva, K. Warren, M. Pintilie, and S. J. Done
Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study
Clin. Cancer Res., July 15, 2008; 14(14): 4446 - 4454.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Rizki, V. M. Weaver, S.-Y. Lee, G. I. Rozenberg, K. Chin, C. A. Myers, J. L. Bascom, J. D. Mott, J. R. Semeiks, L. R. Grate, et al.
A Human Breast Cell Model of Preinvasive to Invasive Transition
Cancer Res., March 1, 2008; 68(5): 1378 - 1387.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Dolled-Filhart, L. Ryden, M. Cregger, K. Jirstrom, M. Harigopal, R. L. Camp, and D. L. Rimm
Classification of breast cancer using genetic algorithms and tissue microarrays.
Clin. Cancer Res., November 1, 2006; 12(21): 6459 - 6468.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A E Pinto, L Roque, R Rodrigues, S Andre, and J Soares
Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisation
J. Clin. Pathol., April 1, 2006; 59(4): 367 - 372.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. E. Stange, B. Radlwimmer, F. Schubert, F. Traub, A. Pich, G. Toedt, F. Mendrzyk, U. Lehmann, R. Eils, H. Kreipe, et al.
High-Resolution Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and 16p with Histologic and Genetic Subgroups of Invasive Breast Cancer
Clin. Cancer Res., January 15, 2006; 12(2): 345 - 352.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
J Packeisen, K Nakachi, W Boecker, B Brandt, and H Buerger
Cytogenetic differences in breast cancer samples between German and Japanese patients
J. Clin. Pathol., October 1, 2005; 58(10): 1101 - 1103.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Tanaka, Y. Hashimoto, T. Ito, T. Okumura, T. Kan, G. Watanabe, M. Imamura, J. Inazawa, and Y. Shimada
The Clinical Significance of Aurora-A/STK15/BTAK Expression in Human Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., March 1, 2005; 11(5): 1827 - 1834.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Nessling, K. Richter, C. Schwaenen, P. Roerig, G. Wrobel, S. Wessendorf, B. Fritz, M. Bentz, H.-P. Sinn, B. Radlwimmer, et al.
Candidate Genes in Breast Cancer Revealed by Microarray-Based Comparative Genomic Hybridization of Archived Tissue
Cancer Res., January 15, 2005; 65(2): 439 - 447.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. W. M. Loo, D. I. Grove, E. M. Williams, C. L. Neal, L. A. Cousens, E. L. Schubert, I. N. Holcomb, H. F. Massa, J. Glogovac, C. I. Li, et al.
Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes
Cancer Res., December 1, 2004; 64(23): 8541 - 8549.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Rennstam, M. Ahlstedt-Soini, B. Baldetorp, P.-O. Bendahl, A. Borg, R. Karhu, M. Tanner, M. Tirkkonen, and J. Isola
Patterns of Chromosomal Imbalances Defines Subgroups of Breast Cancer with Distinct Clinical Features and Prognosis. A Study of 305 Tumors by Comparative Genomic Hybridization
Cancer Res., December 15, 2003; 63(24): 8861 - 8868.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Dyer, E. Prebble, V. Davison, P. Davies, P. Ramani, D. Ellison, and R. Grundy
Genomic Imbalances in Pediatric Intracranial Ependymomas Define Clinically Relevant Groups
Am. J. Pathol., December 1, 2002; 161(6): 2133 - 2141.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Climent, J. A. Martinez-Climent, D. Blesa, M. J. Garcia-Barchino, R. Saez, D. Sanchez-Izquierdo, P. Azagra, A. Lluch, and J. Garcia-Conde
Genomic Loss of 18p Predicts an Adverse Clinical Outcome in Patients with High-Risk Breast Cancer
Clin. Cancer Res., December 1, 2002; 8(12): 3863 - 3869.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. E. Moore, A. H. Smith, C. Eng, D. Kalman, S. DeVries, V. Bhargava, K. Chew, D. Moore II, C. Ferreccio, O. A. Rey, et al.
Arsenic-Related Chromosomal Alterations in Bladder Cancer
J Natl Cancer Inst, November 20, 2002; 94(22): 1688 - 1696.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Dellas, J. Torhorst, E. Schultheiss, M. J. Mihatsch, and H. Moch
DNA Sequence Losses on Chromosomes 11p and 18q Are Associated with Clinical Outcome in Lymph Node-negative Ductal Breast Cancer
Clin. Cancer Res., May 1, 2002; 8(5): 1210 - 1216.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
O. Saramaki, N. Willi, O. Bratt, T. C. Gasser, P. Koivisto, N. N. Nupponen, L. Bubendorf, and T. Visakorpi
Amplification of EIF3S3 Gene Is Associated with Advanced Stage in Prostate Cancer
Am. J. Pathol., December 1, 2001; 159(6): 2089 - 2094.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A.-M. Cleton-Jansen, D. F. Callen, R. Seshadri, S. Goldup, B. McCallum, J. Crawford, J. A. Powell, C. Settasatian, H. van Beerendonk, E. W. Moerland, et al.
Loss of Heterozygosity Mapping at Chromosome Arm 16q in 712 Breast Tumors Reveals Factors that Influence Delineation of Candidate Regions
Cancer Res., February 1, 2001; 61(3): 1171 - 1177.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
G.-J. Wu, C. S. Sinclair, J. Paape, J. N. Ingle, P. C. Roche, C. D. James, and F. J. Couch
17q23 Amplifications in Breast Cancer Involve the PAT1, RAD51C, PS6K, and SIGMA1B Genes
Cancer Res., October 1, 2000; 60(19): 5371 - 5375.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
F. Forozan, E. H. Mahlamäki, O. Monni, Y. Chen, R. Veldman, Y. Jiang, G. C. Gooden, S. P. Ethier, A. Kallioniemi, and O.-P. Kallioniemi
Comparative Genomic Hybridization Analysis of 38 Breast Cancer Cell Lines: A Basis for Interpreting Complementary DNA Microarray Data
Cancer Res., August 1, 2000; 60(16): 4519 - 4525.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
W.'e. El-Rifai, M. Sarlomo-Rikala, L. C. Andersson, S. Knuutila, and M. Miettinen
DNA Sequence Copy Number Changes in Gastrointestinal Stromal Tumors: Tumor Progression and Prognostic Significance
Cancer Res., July 1, 2000; 60(14): 3899 - 3903.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
S. Hidaka, T. Yasutake, H. Takeshita, M. Kondo, T. Tsuji, A. Nanashima, T. Sawai, H. Yamaguchi, T. Nakagoe, H. Ayabe, et al.
Differences in 20q13.2 Copy Number between Colorectal Cancers with and without Liver Metastasis
Clin. Cancer Res., July 1, 2000; 6(7): 2712 - 2717.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
J. W. Gray and C. Collins
Genome changes and gene expression in human solid tumors
Carcinogenesis, March 1, 2000; 21(3): 443 - 452.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
F. M. Waldman, S. DeVries, K. L. Chew, D. H. Moore II, K. Kerlikowske, and B.-M. Ljung
Chromosomal Alterations in Ductal Carcinomas In Situ and Their In Situ Recurrences
J Natl Cancer Inst, February 16, 2000; 92(4): 313 - 320.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Isola, L. Chu, S. DeVries, K. Matsumura, K. Chew, B. M. Ljung, and F. M. Waldman
Genetic Alterations in ERBB2-amplified Breast Carcinomas
Clin. Cancer Res., December 1, 1999; 5(12): 4140 - 4145.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Richter, U. Wagner, P. Schraml, R. Maurer, G. Alund, H. Knonagel, H. Moch, M. J. Mihatsch, T. C. Gasser, and G. Sauter
Chromosomal Imbalances Are Associated with a High Risk of Progression in Early Invasive (pT1) Urinary Bladder Cancer
Cancer Res., November 1, 1999; 59(22): 5687 - 5691.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Zhao, J. Richter, U. Wagner, B. Roth, P. Schraml, T. Zellweger, D. Ackermann, U. Schmid, H. Moch, M. J. Mihatsch, et al.
Chromosomal Imbalances in Noninvasive Papillary Bladder Neoplasms (pTa)
Cancer Res., September 1, 1999; 59(18): 4658 - 4661.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Shivapurkar, S. Sood, I. I. Wistuba, A. K. Virmani, A. Maitra, S. Milchgrub, J. D. Minna, and A. F. Gazdar
Multiple Regions of Chromosome 4 Demonstrating Allelic Losses in Breast Carcinomas
Cancer Res., August 1, 1999; 59(15): 3576 - 3580.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Dellas, J. Torhorst, F. Jiang, J. Proffitt, E. Schultheiss, W. Holzgreve, G. Sauter, M. J. Mihatsch, and H. Moch
Prognostic Value of Genomic Alterations in Invasive Cervical Squamous Cell Carcinoma of Clinical Stage IB Detected by Comparative Genomic Hybridization
Cancer Res., July 1, 1999; 59(14): 3475 - 3479.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Bissig, J. Richter, R. Desper, V. Meier, P. Schraml, A. A. Schaffer, G. Sauter, M. J. Mihatsch, and H. Moch
Evaluation of the Clonal Relationship between Primary and Metastatic Renal Cell Carcinoma by Comparative Genomic Hybridization
Am. J. Pathol., July 1, 1999; 155(1): 267 - 274.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. N. Nupponen, K. Porkka, L. Kakkola, M. Tanner, K. Persson, A. Borg, J. Isola, and T. Visakorpi
Amplification and Overexpression of p40 Subunit of Eukaryotic Translation Initiation Factor 3 in Breast and Prostate Cancer
Am. J. Pathol., June 1, 1999; 154(6): 1777 - 1783.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Tanaka, M. Kimura, K. Matsunaga, D. Fukada, H. Mori, and Y. Okano
Centrosomal Kinase AIK1 Is Overexpressed in Invasive Ductal Carcinoma of the Breast
Cancer Res., May 1, 1999; 59(9): 2041 - 2044.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Roylance, P. Gorman, W. Harris, R. Liebmann, D. Barnes, A. Hanby, and D. Sheer
Comparative Genomic Hybridization of Breast Tumors Stratified by Histological Grade Reveals New Insights into the Biological Progression of Breast Cancer
Cancer Res., April 1, 1999; 59(7): 1433 - 1436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Kimura, Y. Matsuda, T. Yoshioka, and Y. Okano
Cell Cycle-dependent Expression and Centrosome Localization of a Third Human Aurora/Ipl1-related Protein Kinase, AIK3
J. Biol. Chem., March 12, 1999; 274(11): 7334 - 7340.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R Giet and C Prigent
Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases
J. Cell Sci., January 11, 1999; 112(21): 3591 - 3601.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Collins, J. M. Rommens, D. Kowbel, T. Godfrey, M. Tanner, S.-i. Hwang, D. Polikoff, G. Nonet, J. Cochran, K. Myambo, et al.
Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma
PNAS, July 21, 1998; 95(15): 8703 - 8708.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. N. Nupponen, L. Kakkola, P. Koivisto, and T. Visakorpi
Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas
Am. J. Pathol., July 1, 1998; 153(1): 141 - 148.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. M. Tanner, R. A. Karhu, N. N. Nupponen, A. Borg, B. Baldetorp, T. Pejovic, M. Ferno, D. Killander, and J. J. Isola
Genetic Aberrations in Hypodiploid Breast Cancer : Frequent Loss of Chromosome 4 and Amplification of CyclinD1 Oncogene
Am. J. Pathol., July 1, 1998; 153(1): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Zamostiano, A. Pinhasov, E. Gelber, R. A. Steingart, E. Seroussi, E. Giladi, M. Bassan, Y. Wollman, H. J. Eyre, J. C. Mulley, et al.
Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein
J. Biol. Chem., January 5, 2001; 276(1): 708 - 714.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.